Current status of antiretroviral therapies

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The availability of potent antiretroviral drugs and their use in combination regimens has led to a dramatic decline in the morbidity and mortality associated with HIV infection. Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development.

Original languageEnglish (US)
Pages (from-to)1239-1246
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Volume2
Issue number8
DOIs
StatePublished - 2001

Fingerprint

Pharmaceutical Preparations
HIV Infections
Morbidity
Mortality
Therapeutics

Keywords

  • Antiretrovirals
  • HIV

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Current status of antiretroviral therapies. / Temesgen, Zelalem.

In: Expert Opinion on Pharmacotherapy, Vol. 2, No. 8, 2001, p. 1239-1246.

Research output: Contribution to journalArticle

@article{f71fade001c1473dbda2baad93257f81,
title = "Current status of antiretroviral therapies",
abstract = "The availability of potent antiretroviral drugs and their use in combination regimens has led to a dramatic decline in the morbidity and mortality associated with HIV infection. Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development.",
keywords = "Antiretrovirals, HIV",
author = "Zelalem Temesgen",
year = "2001",
doi = "10.1517/14656566.2.8.1239",
language = "English (US)",
volume = "2",
pages = "1239--1246",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Current status of antiretroviral therapies

AU - Temesgen, Zelalem

PY - 2001

Y1 - 2001

N2 - The availability of potent antiretroviral drugs and their use in combination regimens has led to a dramatic decline in the morbidity and mortality associated with HIV infection. Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development.

AB - The availability of potent antiretroviral drugs and their use in combination regimens has led to a dramatic decline in the morbidity and mortality associated with HIV infection. Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development.

KW - Antiretrovirals

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=0034872860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034872860&partnerID=8YFLogxK

U2 - 10.1517/14656566.2.8.1239

DO - 10.1517/14656566.2.8.1239

M3 - Article

C2 - 11584991

AN - SCOPUS:0034872860

VL - 2

SP - 1239

EP - 1246

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 8

ER -